PARSIPPANY, N.J.--(BUSINESS WIRE)--Feb. 21, 2012--
Pacira
Pharmaceuticals, Inc. (Nasdaq: PCRX) today announced that David
Stack, president and chief executive officer of Pacira Pharmaceuticals,
is scheduled to participate in a panel titled “New Developments in
Neurology” at the RBC Capital Markets Global Healthcare Conference onTuesday, Feb. 28, 2012, at 2:35 p.m. EST at the New York Palace Hotel &
Conference Center in New York City.
About Pacira
Pacira Pharmaceuticals, Inc. (Nasdaq: PCRX) is an emerging specialty
pharmaceutical company focused on the clinical and commercial
development of new products that meet the needs of acute care
practitioners and their patients. The company's current emphasis is the
development of non-opioid products for postsurgical pain control, and
its lead product, EXPAREL® (bupivacaine liposome injectable suspension),
was approved for administration into the surgical site to produce
postsurgical analgesia by the U.S. Food and Drug Administration in
October 2011. EXPAREL and two other commercially available products
utilize the Pacira proprietary product delivery technology DepoFoam®, a
unique platform that encapsulates drugs without altering their molecular
structure and then releases them over a desired period of time.
Additional information about Pacira is available at
http://www.pacira.com.
Source: Pacira Pharmaceuticals, Inc.
Pacira Pharmaceuticals, Inc.
James S. Scibetta, 973-254-3570
Chief
Financial Officer
